Novo's Wegovy, ranges between a weekly price of 2,700 and 4,100; its Ozempic ranges between a monthly price of 8,800 and 11,175
- Business Line
- 2 hours 6 minutes ago
Indian pharma majors Sun Pharma, Dr Reddy's and Glenmark on Saturday announced the launch of their generic versions of semaglutide injection used for diabetes and weight management following the molecule behind products like Ozempic and Wegovy going off patent in India. The prices of the generic versions of semaglutide injection are considerably lower than the prices of the innovator, Novo Nordisk. Sun Pharmaceutical Industries launched its semaglutide injection under the brand names Noveltreat and Sematrinity in India, in all strengths. Noveltreat is indicated for chronic weight management in adults as an adjunct to a reduced calorie diet and increased physical activity and is available in five dose strengths -- 0.25 mg/0.5 ml, 0.5 mg/0.5 ml, 1 mg/0.5 ml, 1.7 mg/0.75 ml, and 2.4 mg/0.75 ml, Sun Pharma said in a statement. Sematrinity is indicated for treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise and is available in t
- Business Standard
- 2 hours 33 minutes ago
The cost to the patient will be 4,200 per month
- Business Line
- 4 hours 24 minutes ago
HDFC Bank said it identified gaps, conducted a review, and took remedial action in line with its policies
- Business Line
- 9 hours 34 minutes ago
Strong domestic demand, protectionist policies in key markets and cost efficiencies position Tata Steel to benefit despite global headwinds and price volatility
- Business Standard
- 17 hours 2 minutes ago
The latest hike comes when players across sectors are coping with escalating costs among other challenges amidst West Asia conflict
- Business Line
- 17 hours 11 minutes ago
HUL denies divestment talks as parent Unilever explores sale of global foods business, including discussions with McCormick & Company
- Business Standard
- 18 hours 14 minutes ago
But, many private sector banks, led by Axis Bank, have continued to register a rise in bad loans in the retail loan book
- Business Line
- 18 hours 51 minutes ago
If ITC stock ends FY2026 in the red, it would mark the second consecutive year of losses and the weakest performance since FY2021.
- Business Standard
- 23 hours 10 minutes ago
Renewed deal will focus on AI-led transformation, cloud modernisation and operational efficiency across Swissport's global aviation operations
- Business Standard
- 1 day ago
